[Clinical study of hydrogen-rich saline in the treatment of moderate to severe allergic rhinitis].
L Jin, S Q Yu, X Zhang, Q Ge, X L Zhang, Y Wang, M L Qin · Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2018
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 20 patients with hydrogen-rich saline in the treatment of moderate to severe allergic rhinitis, hydrogen-enriched saline is safe and effective for allergic rhinitis. These findings add human evidence that helps define the outcomes that did and did not change with molecular hydrogen in this study.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 20 patients with hydrogen-rich saline in the treatment of moderate to severe allergic rhinitis. Hydrogen-enriched saline is safe and effective for allergic rhinitis.
What the Researchers Studied
The researchers studied 20 patients with hydrogen-rich saline in the treatment of moderate to severe allergic rhinitis. The study used a randomized human clinical trial. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Twenty patients with moderate to severe persistent allergic rhinitis were treated with normal saline and hydrogen-rich saline lavage the nasal cavity. Hydrogen-enriched saline is safe and effective for allergic rhinitis.
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is human clinical evidence from a randomized human clinical trial. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 20 patients with hydrogen-rich saline in the treatment of moderate to severe allergic rhinitis. The reported sample size was 20. The study used a randomized human clinical trial.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.